Image

2019 Cannabis Business Award's

Publication of the Year

WEDNESDAY, OCTOBER 15, 2025

 

FMCPG HAS BEEN SERVING

AND REPRESENTING THE CANNABIS PHYSICIAN COMMUNITY

SINCE 2020

 

 

FMCPG MEETING

LINK BELOW 

REGISTER TONIGHT'S MEETING OF THE FMCPG
WEDNESDAY

NOVEMBER 5, 2025

THE

"FLORIDA MEDICAL CANNABIS

PHYSICIAN GROUP"

(FMCPG)

FOR ALL

"MEDICAL MARIJUANA DOCTORS"

AND "MMTC DIRECTORS ONLY "

 

DISCUSS AND UPDATE THE LEGISLATIVE PRIORITIES FOR

2025/2026

 

REVIEW OF THE OMMU AND  CHANGES TO THE DOCTOR'S AND PATIENT INPUT PORTALS ON THE OMMU WEBSITE. 

DOCTORS WITHIN OUR GROUP WILL DISCUSS HOW THEY HAVE BEEN WORKING AROUND SOME OF THE CHANGES

 

REF'S ISSUES AND SOLUTIONS

 

TIME TO RENEW YOUR MEMBER IN FMCPG

CLICK HERE FOR THE MEMBERSHIP FORM

 

USE THIS LINK TO REGISTER FOR THE NEXT MEETING  - WEDNESDAY, NOVEMBER 5, 2025

 

CLICK ON LINK BELOW

JOIN THE NEXT MEETING
OF THE FMCPG

WEDNESDAY

NOVEMBER 5, 2025
 
 

 MEDICAL CANNABIS PHYSICIAN

PROMOTION PACKAGE BY

CANNABIS NEWS FLORIDA 

 

ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks).

 

E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast.

 

The cost of this program is ONLY $500

AND INCLUDES A ONE YEAR MEMBERSHIP IN THE FMCPG

 

**Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100.

 

IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785

 
 

NEWS FROM THE PAST WEEK

RELATING TO THE BUSINESS OF

MMTC'S

IN FLORIDA

 

Click on Company Logo to be Transferred to Web Site

 

Trulieve Rewards

 

Trulieve Rewards is a customer rewards program offering patients and customers in participating states an easy platform to earn points on every purchase at Trulieve dispensaries. We've revamped and refreshed our old cannabis loyalty program to reward cannabis enthusiasts loyal to Trulieve with savings, perks, and points every time they shop for cannabis products

 

JOIN NOW

 
 

CLICK HERE FOR MORE INFORMATION ABOUT THE SUNBURN CANNABIS PROMOTIONS

 
 
 

AYR Wellness Announces Commencement of Restructuring Support Agreement Article 9 Proceedings

MIAMI, Oct. 13, 2025  — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR”) together with its affiliates and subsidiaries (collectively, the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, today announces the next step of its debt restructuring process with its senior noteholders. As contemplated by the Restructuring Support Agreement dated July 30, 2025 (the “RSA”), this next phase of the restructuring will be implemented through a foreclosure sale, conducted by Odyssey Trust Company, in its capacity as collateral trustee (in such capacity, the “Trustee”) for the Company’s senior noteholders (the “Senior Noteholders”). The Trustee, at the direction of Senior Noteholders holding over a majority of the outstanding senior notes, has (a) delivered notifications of disposition of collateral in accordance with the Uniform Commercial Code to conduct a public sale (the “Sale”) of certain collateral assets and equity interests of certain specified AYR subsidiaries (collectively, the “Debtors”) with respect to certain going‑concern operations of the Company in Florida, New Jersey, Nevada, Ohio, Massachusetts, and Pennsylvania (the “Assets”), as more fully set forth in the notification delivered by the Trustee, and (b) published an advertisement with respect to the Sale in the Wall Street Journal and distributed via Cannabis Business Times.

The public auction is scheduled to occur on November 10, 2025, at 10:00 a.m. Eastern Time, at the offices of Paul Hastings LLP, 200 Park Avenue, 26th Floor, New York, NY 10166, and/or virtually via video conference and the Trustee reserves the right to adjourn or postpone the auction without any further notice.

“The commencement of the Article 9 proceedings and public auction process marks the latest milestone in our ongoing restructuring process, said Scott Davido, Interim CEO of AYR. “As we work to transition the ownership of many of the Company’s assets to the successful bidder, throughout this entire process, AYR will continue to fully operate these businesses and continue to deliver the same high quality of products and services.”

READ MORE

AYR Wellness Launches Flower from its First Indoor Cultivation Facility in Florida, Expanding Product Quality and Variety

Registered patients can now obtain new Kynd brand flower offerings at AYR Wellness dispensaries statewide

October 14, 2025  — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces the opening of its first-ever indoor cultivation facility in Florida, marking a major milestone for the Company and its customers in the Sunshine State.

The new 97,580 sq. ft. facility features nearly 50,000 sq. ft. of grow canopy. The site will employ approximately 100 team members across cultivation, operations, and technical roles, with opportunities for both experienced professionals and those beginning their careers in the cannabis industry.

“We’re incredibly proud to open this state-of-the-art indoor cultivation facility in central Florida,” said George DeNardo, President of AYR Wellness. “This new facility, with our existing hybrid greenhouse site in Gainesville, allows AYR to offer patients the best of both worlds: premium, indoor-grown flower with top-shelf quality, and value-driven hybrid greenhouse flower. By listening to what patients want and expanding our suite of offerings, AYR is raising its standards for cannabis while ensuring AYR remains competitive in Florida’s evolving market.”

READ MORE

 

Curaleaf Upsizes Revolving Credit Facility to $100 Million with Needham Bank

Represents the largest revolving credit facility in the U.S. cannabis sector to date

Landmark financing marks a significant step forward for institutional lending in cannabis

STAMFORD, Conn., Oct. 14, 2025  — Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, today announced that it has entered into an amended and restated credit agreement with Needham Bank of its revolving credit facility (the “Credit Facility”), expanding the borrowing capacity from $40 million to $100 million and extending the maturity to up to five years.

Boris Jordan, Chairman and CEO of Curaleaf, said “I couldn’t be prouder of our team for the focus, discipline, and collaboration that made completing this $100 million facility possible. Not only does this increased credit line provide us greater flexibility to execute our strategic plan but also demonstrates the confidence Needham has in our long-term objectives.”

“This first of-its-kind transaction of this scale in the cannabis industry was backed by the direct support and strong conviction of our lenders in our business and future,” said Ed Kremer CFO of Curaleaf. “It represents a significant step toward broader access to capital markets and signals progress toward establishing financial standards in a sector that has historically faced limited institutional participation. We are proud to have longstanding partners who not only champion our vision but also contribute to the advancement of the cannabis industry. This strengthened capital position will be key to advancing our growth initiatives, enhancing operational capabilities, and preserving financial flexibility during this critical phase of industry transformation,” added Mr. Kremer.

READ MORE

 
 
 
 
 
 

Verano Announces Grand Opening of Zen Leaf Antwerp in 19th Century Historic Ohio Train Depot, Offering Cannabis Consumers One of the Most Unique Dispensary Shopping Experiences in the U.S.

Zen Leaf is Located in Antwerp’s Norfolk & Western Train Depot Originally Built in 1880 and Listed on the National Register of Historic Places 

Located at 503 W. River Street, Zen Leaf Antwerp is situated less than five miles from the Indiana border and just a 30-minute drive from Fort Wayne, Indiana’s second most populous city with more than 423,000 metro area residents1

Zen Leaf Antwerp is Verano’s sixth Ohio dispensary, expanding the Company’s statewide vertical footprint that includes Zen Leaf locations in Bowling Green, Canton, Cincinnati, Dayton and Newark, and 22,000 square feet of state-of-the-art cultivation and processing operations in Canton

During Grand Opening weekend, Zen Leaf Antwerp is hosting a job fair onsite at the dispensary October 17th and 18th from 10:00 a.m. to 6:30 p.m., offering aspiring cannabis professionals the opportunity to apply and interview for a variety of positions

Verano’s active operations span 13 states, comprised of 158 dispensaries and 15 cultivation and processing facilities with more than 1.1 million square feet of cultivation capacity

CHICAGO, Oct. 15, 2025 — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the Grand Opening of Zen Leaf Antwerp, located at 503 W. River Street, on October 17, raising the Company’s Ohio dispensary footprint to six statewide locations. Zen Leaf Antwerp will be open Monday through Saturday from 10:00 a.m. to 7:00 p.m. local time.

Zen Leaf Antwerp – situated in the Norfolk and Western Train Depot built in 1880 and listed on the National Register of Historic Places – offers one of the most unique dispensary shopping experiences in the U.S. given its rich history and aesthetic. After opening for curbside pickup earlier this year, Zen Leaf Antwerp’s Grand Opening follows the completion of interior and exterior restoration efforts focused on preserving and honoring the building’s historic character and legacy. The dispensary is also located just five miles from the Indiana border and a 30-minute drive from Fort Wayne, Indiana’s second largest metro area with more than 423,000 residents1.

READ MORE

 
 
 
 
 
 
 
 

Planet 13 Opens its Newest Florida Dispensary in DeLand just off the Busy I-4 Corridor Between Orlando and Daytona

Oct. 13, 2025  — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced the opening of Florida dispensary in DeLand at 309 Woodland Blvd.

Located in the heart of DeLand’s charming downtown near Stetson University, the area is known for its historic brick-lined streets, vibrant local shops, and strong sense of community. Planet 13 DeLand will be open Monday through Saturday from 9 a.m. to 7 p.m. and from 9 a.m. to 7 p.m. on Sundays, 365 days a year.

“We’re thrilled to expand our presence along the bustling I-4 corridor in DeLand while serving the nearby communities of Deltona and Orange City with Planet 13’s award-winning products,” said Bob Groesbeck, Co-CEO of Planet 13. “This location is downtown in a popular shopping area with high visibility and accessibility. We look forward to bringing our best-in-class cannabis products and unmatched customer service to residents in DeLand and the surrounding area.”

Grand opening celebrations are planned on November 15, 2025, with exciting perks, exclusive swag and local vendors highlighting the event.

READ MORE

 

FINO BRANDS, INC

 
 
 
 
 

PROSPERITY MEDICAL, LLC

 

THERATRUE FLORIDA

 
 

Most people know that eliminating 280E would improve cannabis companies’ cash flows and debt capacity; however, the exact mechanism of this improvement and the extent of the improvement are not widely understood.

This week's Viridian Chart of the Week explores the impact of the elimination of 280E on three types of operators, High Performers, Medium Performers, and Low Performers, in order to model the degree to which S3 would impact their relative debt capacity.

We modeled hypothetical firms, each having $1 of sales.

The High, Medium, and Low performance categories are defined by gross margin: high performers at 50%, medium performers at 40%, and low performers at 30%. We maintained operating expenses at 20% for all three performance categories.
 

We calculate taxes at a 25% rate based on gross profit under 280E and on pretax income under S3.
 

We also varied interest rates across high-, medium-, and low-performing categories at 9%, 12%, and 16%, respectively.

The key realization for modeling debt capacity is that it is not limited by interest coverage as much as by payback capacity. Lenders do not just want to see that companies can “carry” their debt; they also want to know that they can actually pay it off in a reasonable period of time. We have used a 5-year debt payback, calculated as Debt/Funds from Operations, as our guideline.

With 280E in effect, high-performing cannabis companies can afford only approximately 2.0x debt/EBITDA and still pay back debt in 5 years. As you move down the performance levels, debt capacity under 280E drops to 1.6x for medium performers and 0.7x for low performers.

After rescheduling, debt capacity rises to around 3.2x for all performance levels.

The chart shows that the relative increase in debt capacity becomes more pronounced for lower-performing classes.

Some commentators have argued that S3 would chiefly benefit larger, more profitable enterprises; however, our hypothetical model’s results contradict this view.
Post S3, high-performance companies would be able to safely maintain about $0.95 in debt for every $1 in revenue, up about 58%. Low performers would be able to support around $0.33 debt for every $1 of revenue, an increase of approximately 371%.

For More Analysis View This Week's Viridian Chart of the Week

 

About Viridian Capital Advisors

Since launching in 2014, Viridian Capital Advisors has become one of the most respected and experienced advisory and M&A firms specializing in the cannabis industry. We provide a wide range of services, including:

Strategic Advisory Consulting: Including valuation, financial modeling, restructuring and fairness opinions.

Mergers & Acquisitions:  Transaction advisory and execution.

Capital Raises: Including debt and equity.

 

Many of our assignments begin with a basic question: "What should I do now?"  

Raise capital to expand? What kind of capital is most appropriate? 
 

Acquire another company? What are the advantages and pitfalls? 

Sell my company?  What valuations can i achieve?  What transaction structures are possible?


Put our experience, data and depth of senior talent behind your next transaction.

Contact

Scott Greiper
CEO
Viridian Capital Advisors, LLC
646.330.0704
sgreiper@viridianca.com

Frank Colombo
Managing Director
Viridian Capital Advisors, LLC
914.523.4730
fcolombo@viridianca.com

 
 

NATIONAL AND INTERNATIONAL NEWS

Tilray Medical Announces Expansion Plans in Panama, Strengthening Global Cannabis Leadership and Accelerating International Growth

Oct. 13, 2025  — Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, has announced plans to expand its medical cannabis operations into Panama. In connection with its expansion into Panama, Tilray has entered into a joint venture with Top Tech Global Inc. (“Top Tech”), whose members have extensive experience in the distribution of medical devices since 2014.  Together, Tilray and Top Tech, through their joint venture company, Solana Life Group, have received a medical cannabis license issued by the National Directorate of Pharmacy and Drugs in Panama authorizing the cultivation, manufacturing, import, export, distribution and sale of medical cannabis in Panama.

With this joint venture partnership, Tilray Medical will leverage both its global expertise, as well as the local expertise of Top Tech to facilitate the launch and ongoing distribution of medical cannabis products across Panama, thereby enhancing access for patients in need. Tilray is committed to supporting the Panamanian medical community by providing education, maintaining a reliable supply chain, and offering a comprehensive portfolio of cannabinoid-based therapies. 

READ MORE

 

Tilray Brands Reports Strong First Quarter Fiscal 2026 Results, Highlighting Continued Growth with Record Q1 Net Revenue of $210 Million and Net Income

Operational Efficiencies and Focus on Profitability Drove Net Income of $1.5 Million, Adjusted EBITDA Increased 9% to $10 Million and Net Cash Used in Operations Improved by $34 Million Year-Over-Year

Canadian Adult-Use Cannabis Gross Revenue Increased 12%, Maintaining the #1 Position in Revenue and Expanding Market Share; International Cannabis Revenue Grew 10% Year-Over-Year

Balance Sheet Strengthened to $265 Million in Cash; Net Debt Reduced to $4 Million

Reiterates Fiscal Year 2026 Adjusted EBITDA Outlook of $62 Million – $72 Million

NEW YORK and LONDON and LEAMINGTON, Ontario, Oct. 09, 2025 — Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today reported financial results for its first fiscal quarter ended August 31, 2025. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.

Irwin D. Simon, Chairman and Chief Executive Officer, stated, “As we enter fiscal 2026, Tilray’s first quarter results underscore the effectiveness of our strategic vision and disciplined execution. Achieving a record Q1 net revenue of $210 million, delivering net income, and fortifying our balance sheet are not just milestones, they are proof points of our commitment to building sustainable growth, operational excellence, and unlocking value for our shareholders. Our global platform positions Tilray Brands not just to participate in, but to lead, the evolution of the global cannabis, beverage, and wellness sectors.”

READ MORE

 

Cronos launches SOURZ by Spinach® Fully Blasted Multipacks

TORONTO, Oct. 09, 2025 — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, today announced that its popular SOURZ by Spinach® Fully Blasted gummies will now be available in new multipack formats. The SOURZ by Spinach® Fully Blasted Multipacks with liquid diamond-infused gummies are now available in five of its most popular flavors, offering consumers more choice, convenience, and value when purchasing Canada’s favorite cannabis edible.

“Our new SOURZ by Spinach® Fully Blasted Multipacks are designed to give consumers the same great taste, consistency, and experience they expect from our gummies, with the added benefit of more variety and convenience,” said Mike Gorenstein, Chairman, President, and CEO, Cronos. “We know that consumers have been eager to try our gummies in this format and we are excited for the opportunity to offer a product that meets their needs while delivering great value. The arrival of products like multipacks will give consumers more reasons to stay loyal to trusted brands like SOURZ by Spinach®.”

READ MORE

 

BELOW ARE THE  LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND

DISPENSARIES IN THE STATE OF FLORIDA

Link to current Qualified Medical Marijuana Physicians in Florida>

Listing of MMTC dispensing facilities>

 

SUMMARY OF THE MEDICAL CANNABIS PROGRAM IN FLORIDA ANNUAL REPORT JULY 2022- JUNE 2023

 

CLICK ON IMAGE BELOW FOR A PDF COPY

 

 QUALIFIED PATIENTS

OVER 928,000

AND

736

DISPENSING LOCATIONS

Image

LATEST OMMU REPORTS FROM OFFICE OF MEDICAL  MARIJUANA USE IN THE STATE OF FLORIDA

Highlights from 
OCTOBER 10, 2025

Report 

BY THE NUMBERS

Qualified Patients: (Active ID Card)

OCT       10  2025            928,083

OCT       03  2025            926,467

SEPT     26  2025            925,084

SEPT     19  2025            924,797

SEPT     12  2025            924,473

SEPT     05  2025            923,918

 

Patients Last Week: 1,616

Qualified Ordering Physicians: 2,439

New Doctors Last Week:  4

 

Reporting Period:  OCT 3   -  OCT 9, 2025 

Amount of Medical Marijuana Dispensed -  (mgs THC) 388,206,388

Amount of Low-THC Cannabis Dispensed -  (mgs CBD)  0

Amount of Marijuana in a From for Smoking (oz) 137,848.018

Approved Dispensing Locations: 736

ADDED LAST WEEK 2

Planet 13 - Deland

Cookies - Sanford

CLICK HERE FOR CURRENT OMMU REPORT
Alternate text
 

UPCOMING MEETING AND CONFERENCES

LOOK FOR IN FUTURE ISSUES

 

ADVERTISEMENT OPPORTUNITIES

 

If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.

 

Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:

· MMTC PROMOS LISTED IN EACH E-NEWSLETTER 
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters


For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com

 

Click Here to Unsubscribe

 

CANNABIS NEWS FLORIDA

{YOURCOMPANY.ADDRESS}

{COPYRIGHT.YEAR}